DR.NOAH Biotech
PrivateLast Round
Series B
May 1, 2022
Total Funding Raised
$16.99M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
DR.NOAH Biotech is a biotechnology company that develops innovative drug combinations for orphan diseases using its proprietary AI-driven drug discovery platform, ARK.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
DR.NOAH Biotech Comparables
Compare DR.NOAH Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Healx | 87% | |
| Arontier | 85% | |
| PharmCADD Co., Ltd. | 84% |
DR.NOAH Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | May 1, 2022 | ||||
| Strategic | Nov 1, 2020 | ||||
| Series A | Aug 12, 2020 | ||||
| Pre Seed | Dec 1, 2018 |
DR.NOAH Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BNH INVESTMENT | Pre Seed, Series A |
| CKD Venture Capital | Series B |
| KB Investment | Series A |
| Pathfinder H | Series B |
| L&S Venture Capital | Series B |
| LSK Investment | Pre Seed |
| Yuanta Investment | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 44% MoM.
- May 16, 2026
Monthly visitors increased 6526% from 23 to 1.5K.
DR.NOAH Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about DR.NOAH Biotech's valuation, stock price, and market status.
Is DR.NOAH Biotech a public or private company?
DR.NOAH Biotech is a private company.
What is the current stock price of DR.NOAH Biotech?
DR.NOAH Biotech is a private company with no public stock price. Caplight tracks DR.NOAH Biotech's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is DR.NOAH Biotech worth (valuation)?
Valuation information for DR.NOAH Biotech is not publicly available.
Can I buy DR.NOAH Biotech stock?
DR.NOAH Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was DR.NOAH Biotech's last funding round?
DR.NOAH Biotech's most recent funding round was Series B on May 1, 2022.
Who are the main investors in DR.NOAH Biotech?
Key investors in DR.NOAH Biotech include BNH INVESTMENT.
Will DR.NOAH Biotech IPO soon?
No public IPO plans have been announced for DR.NOAH Biotech.
How can I track DR.NOAH Biotech secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor DR.NOAH Biotech's secondary market activity and sign up for updates.